163
Views
17
CrossRef citations to date
0
Altmetric
Original Articles

Anti-hepatotoxic activity of cichotyboside, a sesquiterpene glycoside from the seeds of Cichorium intybus

, , &
Pages 218-223 | Received 29 Aug 2006, Accepted 27 Apr 2007, Published online: 11 Mar 2008
 

Abstract

The seeds of Cichorium intybus L. (Asteraceae) afforded a new guaianolide sesquiterpene glycoside, cichotyboside, which was characterized as 2α, 6β, 7β, 15-tetrahydroxy-1 (10), 4 (5)-diene-guaian-9α, 12-olide-7-O-β-caffoyl-15-O-β-D-glucoside (1) by means of spectral methods. Cichotyboside (1) exhibited a significant anti-hepatotoxic activity against CCl4 induced toxicity in Wistar rats, wherein it reduced the elevated levels of liver enzymes such as serum glutamate oxaloacetate transaminase (SGOT) by 52 units/ml; SGPT 38 units/ml; ALKP 24.97 units/ml and 7.54 g/dl, 5.48 g/dl increase in total protein and albumin, respectively. It was observed that cichotyboside (1) decreased the level of ALKP comparable with that of standard drug silymarin, exhibiting an 88% decrease in comparison to silymarin (92%) and increased the level of total albumin 85% in comparison to silymarin (89%) against intoxicated control. Whereas, the levels of SGOT and SGPT were also decreased considerably in comparison to standard and intoxicated control.

Acknowledgements

The authors are thankful to the Head Department of Pharmaceutical Chemistry, Faculty of Pharmacy, and Jamia Hamdard for providing necessary research facilities and to the in-charge, Central Animal Facility, Jamia Hamdard, and New Delhi for providing rats and other related facilities for pharmacological activities.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.